2008
DOI: 10.1093/hmg/ddn221
|View full text |Cite
|
Sign up to set email alerts
|

Polycystin-2 down-regulates cell proliferation via promoting PERK-dependent phosphorylation of eIF2α

Abstract: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the formation of renal, hepatic and pancreatic cysts and by non-cystic manifestations such as abnormal vasculature and embryo left-right asymmetry development. Polycystin-2 (PC2), in which mutations account for 10-15% of ADPKD, was previously shown to down-regulate cell proliferation, but the underlying mechanism was not elucidated. Here, we demonstrate that PC2, but not pathogenic mutants E837X and R872X, represses cell proliferation thr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
44
1

Year Published

2009
2009
2019
2019

Publication Types

Select...
6
4

Relationship

2
8

Authors

Journals

citations
Cited by 51 publications
(46 citation statements)
references
References 36 publications
1
44
1
Order By: Relevance
“…PC2 expression has a negative effect on cell proliferation in cell culture models (40,41), whereas PC2 overexpression in animal models leads to cyst formation (42), suggesting that the level of PC2 must be tightly controlled to prevent cyst formation. It is possible that tight regulation of PC2 as well as PC1 is required to prevent cyst formation.…”
Section: Discussionmentioning
confidence: 99%
“…PC2 expression has a negative effect on cell proliferation in cell culture models (40,41), whereas PC2 overexpression in animal models leads to cyst formation (42), suggesting that the level of PC2 must be tightly controlled to prevent cyst formation. It is possible that tight regulation of PC2 as well as PC1 is required to prevent cyst formation.…”
Section: Discussionmentioning
confidence: 99%
“…Cell Viability Assays-These assays were performed as described (23). Briefly, the cells were cultured in eight separate wells of a 96-well plate.…”
Section: Methodsmentioning
confidence: 99%
“…16,22,24 Coimmunoprecipitation, membrane fractionation, and Western blot analyses were performed as described previously. 16,22,24,28 …”
Section: Isolated Cardiomyocyte Contractilitymentioning
confidence: 99%